Vaccinex (NASDAQ:VCNX) Shares Down 47.6% – What’s Next?

Vaccinex, Inc. (NASDAQ:VCNX)’s stock price dropped 47.6% during trading on Thursday . The stock traded as low as $0.52 and last traded at $0.52. Approximately 4,332 shares changed hands during trading, a decline of 92% from the average daily volume of 57,184 shares. The stock had previously closed at $1.00.

Vaccinex Stock Performance

The firm has a market capitalization of $1.56 million, a PE ratio of -0.01 and a beta of 1.10. The firm has a fifty day moving average of $0.94 and a 200 day moving average of $2.08.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Vaccinex stock. Point72 Asset Management L.P. boosted its holdings in shares of Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 166,000 shares of the company’s stock after purchasing an additional 49,454 shares during the quarter. Point72 Asset Management L.P. owned approximately 9.60% of Vaccinex worth $564,000 at the end of the most recent quarter. Institutional investors own 50.11% of the company’s stock.

About Vaccinex

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.